University of Michigan-Rogel Cancer Center: Zhou Gets $2.9M to Develop a System to Predict Outcomes in Multiple Myeloma
April 12, 2024
April 12, 2024
ANN ARBOR, Michigan, April 12 (TNSres) -- The University of Michigan's Rogel Cancer Center issued the following news release:
By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It's a cancer that's considered incurable, with survival ranging from less than a year to more than a decade, depending on the exte . . .
By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It's a cancer that's considered incurable, with survival ranging from less than a year to more than a decade, depending on the exte . . .